Logo do repositório
 
Publicação

Fibrinogen–erythrocyte binding and hemorheology measurements in the assessment of essential arterial hypertension patients

dc.contributor.authorGuedes, Ana Filipa
dc.contributor.authorMoreira, Carlos
dc.contributor.authorNogueira, José B.
dc.contributor.authorSantos, Nuno C.
dc.contributor.authorCarvalho, Filomena Almeida
dc.date.accessioned2019-04-12T15:15:15Z
dc.date.available2019-04-12T15:15:15Z
dc.date.issued2019
dc.descriptionThis journal is © The Royal Society of Chemistry 2019pt_PT
dc.description.abstractSome studies have reported a positive association between plasma fibrinogen levels, erythrocyte aggregation and essential arterial hypertension (EAH). The aim of this study was to understand how the interaction between fibrinogen and its erythrocyte membrane receptor is altered in EAH. EAH patients (n = 31) and healthy blood donors (n = 65) were enrolled in the study. EAH patients were therapeutically controlled for the disease, presenting a systolic blood pressure between 108 and 180 mmHg and a diastolic blood pressure between 66 and 123 mmHg. Clinical evaluation included blood pressure monitoring, electrocardiography, echocardiography and blood cell count. The hemorheological parameters were also analyzed. Fibrinogen–erythrocyte binding force and frequency were evaluated quantitatively, at the single-molecule level, using atomic force microscopy (AFM). Changes in erythrocyte elasticity were also evaluated. Force spectroscopy data showed that the average fibrinogen–erythrocyte binding forces increase from 40.4 ± 3.0 pN in healthy donors to 73.8 ± 8.1 pN in patients with EAH, despite a lower binding frequency for patients compared to the control group (7.9 ± 1.6% vs. 27.6 ± 4.2%, respectively). Elasticity studies revealed an increase of erythrocyte stiffness in the patients. The stronger fibrinogen binding to erythrocytes from EAH patients and alteration in cell elasticity may lead to changes in the whole blood flow. The patients’ altered hemorheological parameters may also contribute to these blood flow perturbations. The transient bridging of two erythrocytes, by the simultaneous binding of fibrinogen to both of them, promoting erythrocyte aggregation, could represent an important cardiovascular risk factor.pt_PT
dc.description.sponsorshipThis work was supported by Fundação para a Ciência e a Tecnologia – Ministério da Ciência, Tecnologia e Ensino Superior (FCT-MCTES, Portugal) grants PTDC/QUI-BIQ/119509/2010 and PTDC/BBB-BMD/6307/2014, as well as the fellowship SFRH/BD/84414/2012 to AFG. This work was also supported by the UID/BIM/50005/2019 project, funded by FCTMCTES through Fundos do Orçamento do Estado.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationNanoscale, 2019, 11, 2757-–2766pt_PT
dc.identifier.doi10.1039/c8nr04398apt_PT
dc.identifier.issn2040-3364
dc.identifier.urihttp://hdl.handle.net/10451/37909
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherRoyal Society of Chemistrypt_PT
dc.relationMolecular interactions of circulating fibrinogen as a risk factor for cardiovascular and cerebrovascular pathologies
dc.relationInstituto de Medicina Molecular
dc.relation.publisherversionhttps://pubs.rsc.org/en/Journals/JournalIssues/NR#!recentarticles&advpt_PT
dc.titleFibrinogen–erythrocyte binding and hemorheology measurements in the assessment of essential arterial hypertension patientspt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.awardTitleMolecular interactions of circulating fibrinogen as a risk factor for cardiovascular and cerebrovascular pathologies
oaire.awardTitleInstituto de Medicina Molecular
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FQUI-BIQ%2F119509%2F2010/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FBBB-BMD%2F6307%2F2014/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/SFRH/SFRH%2FBD%2F84414%2F2012/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UID%2FBIM%2F50005%2F2019/PT
oaire.citation.endPage2766pt_PT
oaire.citation.startPage2757pt_PT
oaire.citation.titleNanoscalept_PT
oaire.citation.volume11pt_PT
oaire.fundingStream3599-PPCDT
oaire.fundingStream3599-PPCDT
oaire.fundingStreamSFRH
oaire.fundingStream6817 - DCRRNI ID
person.familyNameGuedes
person.familyNameSantos
person.familyNameCarvalho
person.givenNameAna Filipa
person.givenNameNuno
person.givenNameFilomena
person.identifier.ciencia-idCD13-5E3A-A3C5
person.identifier.ciencia-id4615-4AEC-8D91
person.identifier.orcid0000-0001-6768-1718
person.identifier.orcid0000-0002-0580-0475
person.identifier.orcid0000-0001-6088-3894
person.identifier.ridN-7248-2013
person.identifier.ridM-9202-2013
person.identifier.scopus-author-id55940818300
person.identifier.scopus-author-id7103069694
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.rightsrestrictedAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication7855d562-098c-4bdc-8980-c240be6a8d18
relation.isAuthorOfPublication4656d912-5a2d-4c80-8921-2bcba3aa441a
relation.isAuthorOfPublication547cb993-880c-4608-b1e0-493ad469eecb
relation.isAuthorOfPublication.latestForDiscovery7855d562-098c-4bdc-8980-c240be6a8d18
relation.isProjectOfPublication0482037e-233f-4132-9eac-bd15e2202820
relation.isProjectOfPublicationab8a6a0e-d04e-405e-9cf1-e3a92e0d8e06
relation.isProjectOfPublication17349880-8f92-460a-8f4f-1e055f7cce86
relation.isProjectOfPublication67254677-568f-4a05-be7b-4d76decd1bc0
relation.isProjectOfPublication.latestForDiscovery17349880-8f92-460a-8f4f-1e055f7cce86

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
Fibrinogen–erythrocyte.pdf
Tamanho:
1.52 MB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.2 KB
Formato:
Item-specific license agreed upon to submission
Descrição: